Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
46,239,275
-
Total 13F shares
-
13,322,471
-
Share change
-
-706,107
-
Total reported value
-
$237,310,555
-
Put/Call ratio
-
70%
-
Price per share
-
$17.84
-
Number of holders
-
76
-
Value change
-
-$16,609,336
-
Number of buys
-
31
-
Number of sells
-
41
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q1 2020
As of 31 Mar 2020,
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,322,471 shares.
The largest 10 holders included
MENORA MIVTACHIM HOLDINGS LTD., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Wildcat Capital Management, LLC, Phoenix Holdings Ltd., Migdal Insurance & Financial Holdings Ltd., BAKER BROS. ADVISORS LP, Clal Insurance Enterprises Holdings Ltd, STATE STREET CORP, and FMR LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.